EGFR and melanoma: Prerequisite for development of this mechanism of drug resistance is the upregulation of EGFR, since melanoma cells devoid of EGFR expression are sensitive to vemurafenib, lacking this feedback activation, and the ectopic expression of EGFR induces resistance to PLX4032 in melanoma cells [9].